₹ 1,454.90
-19.50 (-1.32%)
A
Alivus Life Sciences
₹ 1,454.90
Alivus Life Sciences EPS Summary
The latest quarterly EPS of Alivus Life Sciences as of Q2 Sep 2026 stands at ₹16.02. This is a 22.85% growth quarter on quarter and 51.13% growth same quarter last year. For the FY2026 the EPS of Alivus Life Sciences stands at ₹45.99. This is a 16.05% growth compared with FY2025.
Alivus Life Sciences EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

